INTRODUCTION Contributed by: Nicola Dagg, Daniel Lim, Jin Ooi and Alex Magnusdottir, Kirkland & Ellis International LLP
Jin Ooi is a patent litigator at Kirkland & Ellis. He has worked on matters in the pharmaceutical, chemistry, biotech and life sciences fields (second medical use, biologics/
Alex Magnusdottir is an associate in Kirkland & Ellis International LLP’s IP litigation practice in London. Alex has trial and advisory experience across the IP spectrum with a particular
biosimilars, small molecules, DNA sequencing, vaccines, and transgenic animal platforms for antibody discovery), in the medical device space (cochlear implants, and bone cements), and in the FMCG and consumer products sector (reduced-risk products including tobacco heating products and e-cigarettes, shaving razors, dishwashing tablets, and coffee pods and capsules). Jin’s cases are often multi-jurisdictional, requiring significant cross-border co-ordination across multiple forums. His dual qualifications in law and pharmacology give him a special insight into, and understanding of, his clients’ legal needs and commercial and regulatory imperatives.
focus on pharmaceutical, biotechnology and medical device patents, and product life cycle advice. Her case experience includes oncology, molecular biology, antibodies, medical devices, and SPCs and medical devices. She works on high value, cross- border disputes dealing with complex technical and patent issues. Alex holds a PhD in neuroscience which gives her particular insight into the challenges facing IP clients.
Kirkland & Ellis International LLP 30 St Mary Axe London EC3A 8AF United Kingdom
Tel: +44 20 7469 2150 Fax: +44 20 7469 2001 Email: nicola.dagg@kirkland.com Web: www.kirkland.com
5
CHAMBERS.COM
Powered by FlippingBook